Determining clinically meaningful decline in preclinical Alzheimer disease

episode

Neurology Minute not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Respect the brawl 58 min · 21 Sep 2026 · Football Ramble

Unfinished Business: Danny Sheehan - The Beings, Contact & Disclosure | Members Preview 1h 38m · 21 Sep 2026 · That UFO Podcast

NPR News: 09-21-2026 7AM EDT 4 min · 21 Sep 2026 · NPR News Now

Hollywood’s Tech Founder Villain Era & Meta’s Muse Soars to Top of App Store 26 min · 21 Sep 2026 · Morning Brew Daily

7AM ET 09/21/2026 Newscast 3 min · 21 Sep 2026 · Fox News Hourly Update

Trump-Xi Summit Preparations, Oil Falls, More 8 min · 21 Sep 2026 · Bloomberg News Now

Report any issue

Source

Recorded23 Jul 2019

Publisherneurologyminute.libsyn.com ↗

Handlerec:10219019

Show notes

Dr. Philip Insel provides the main findings of his paper on determining clinically meaningful decline in preclinical Alzheimer disease.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in